Complete Story
07/18/2025
2025 OAPA Annual Conference - CME #15 (On-Demand)
“Beyond the Pill: Exploring Options for Treatment Resistant Depression"
Presented by Mike Czajka, MPAS, PA-C, Cleveland Clinic
Learning Objectives:
-
Distinguish between clinical and payer definitions of treatment-resistant depression (TRD), and explore how these differences impact clinical decision-making and treatment authorization
-
Compare the efficacy, safety, and patient selection criteria for FDA-cleared interventional treatments, including repetitive TMS (rTMS), iTBS, SAINT protocols, electroconvulsive therapy (ECT), and intranasal esketamine
-
Review the latest evidence and regulatory status of novel interventions for TRD
-
Outline best practices and common pitfalls in pharmacologic and non-pharmacologic management of TRD, including current evidence-based strategies and promising emerging options.
Speaker Biography: